Pharmaceutical

Juvenescence enhances AI drug discovery with Ro5 acquisition

Juvenescence has acquired Ro5 to enhance its AI/machine learning capabilities and improve research and development.

Jun 7, 2025 - 06:00
Juvenescence enhances AI drug discovery with Ro5 acquisition
Juvenescence has acquired Ro5 to enhance its AI/machine learning capabilities and improve research and development.
Read the original article

Tags:

Previous Article

ADHD drugs back in the spotlight after study debunks rising prevalence

Next Article

EC authorises Sydnexis’ paediatric myopia treatment

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Bayer looks to expand Kerendia label to include heart failure

Bayer looks to expand Kerendia label to include heart f...

Sep 1, 2023

CRISPR gene editing on human embryos may have dangerous consequences, says new study

CRISPR gene editing on human embryos may have dangerous...

Jun 29, 2023

Delivery and manufacturing hurdles remain in the cell and gene therapy

Delivery and manufacturing hurdles remain in the cell a...

Mar 22, 2024